Assembly Biosciences (ASMB) Stock Statistics & Valuation Metrics

Assembly Biosciences has a market cap or net worth of $140.91M. The enterprise value is $121.97M.

Assembly Biosciences has 7,637,553 shares outstanding. The number of shares has decreased by -2.65% in one year.

Assembly Biosciences’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is -63.76%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Assembly Biosciences had revenue of 28.52M and earned -40.18M in profits. Earnings per share was -6.69.

In the last 12 months, operating cash flow was -56.19M and capital expenditures -14.00K, giving a free cash flow of -56.21M billion.

Assembly Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Assembly Biosciences upcoming earnings date is Aug 6, 2025, After Close (Confirmed).

Assembly Biosciences as a current ratio of 2.42, with Debt / Equity ratio of 11.13%

In the past 12 months, Assembly Biosciences has paid 330.00K in taxes.

Assembly Biosciences EV to EBITDA ratio is -1.31, with an EV/FCF ratio of -1.16.

Assembly Biosciences has $91.03M in cash and marketable securities with $3.02M in debt, giving a net cash position of -$88.01M billion.

Gross margin is 99.72%, with operating margin of -159.26%, and net profit margin of -140.87%.

The average price target for Assembly Biosciences is $30.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy